| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $470,008 ) |
| | 2023 | 2023 | REGION HOVEDSTADEN | KONGENS VAENGE 2 | HILLEROD | | | | DNK | R01MH124789 | Road Map to Precision Psychiatry: Comprehensive Investigation of Chromosomal Anomalies (PsychMap) | 000 | 3 | NIH | 2/23/2023 | $470,008 |
|
| Issue Date FY: 2022 ( Subtotal = $859,942 ) |
| | 2022 | 2022 | REGION HOVEDSTADEN | KONGENS VAENGE 2 | HILLEROD | | | | DNK | R01CA236816 | Prenatal Exposure to Endocrine Disrupting Chemicals and Risk of Testicular Cancer (DISRUPT) | 000 | 3 | NIH | 6/8/2022 | $261,807 |
| | 2022 | 2022 | REGION HOVEDSTADEN | KONGENS VAENGE 2 | HILLEROD | | | | DNK | R01MH124789 | Road Map to Precision Psychiatry: Comprehensive Investigation of Chromosomal Anomalies (PsychMap) | 000 | 2 | NIH | 2/18/2022 | $444,444 |
| | 2022 | 2022 | REGION HOVEDSTADEN | KONGENS VAENGE 2 | HILLEROD | | | | DNK | R01AA025071 | Glucagon-like peptide-1 modulation of alcohol effects | 000 | 6 | NIH | 7/19/2022 | $104,306 |
| | 2022 | 2022 | REGION HOVEDSTADEN | KONGENS VAENGE 2 | HILLEROD | | | | DNK | R01MH124789 | Road Map to Precision Psychiatry: Comprehensive Investigation of Chromosomal Anomalies (PsychMap) | 001 | 2 | NIH | 6/21/2022 | $49,385 |
|
| Issue Date FY: 2021 ( Subtotal = $1,086,792 ) |
| | 2021 | 2021 | REGION HOVEDSTADEN | KONGENS VAENGE 2 | HILLEROD | | | | DNK | R01MH124789 | Road Map to Precision Psychiatry: Comprehensive Investigation of Chromosomal Anomalies (PsychMap) | 001 | 1 | NIH | 5/5/2021 | $53,027 |
| | 2021 | 2021 | REGION HOVEDSTADEN | KONGENS VAENGE 2 | HILLEROD | | | | DNK | R01CA236816 | Prenatal Exposure to Endocrine Disrupting Chemicals and Risk of Testicular Cancer (DISRUPT) | 000 | 2 | NIH | 3/17/2021 | $406,906 |
| | 2021 | 2021 | REGION HOVEDSTADEN | KONGENS VAENGE 2 | HILLEROD | | | | DNK | R01MH124789 | Road Map to Precision Psychiatry: Comprehensive Investigation of Chromosomal Anomalies (PsychMap) | 000 | 1 | NIH | 3/25/2021 | $471,750 |
| | 2021 | 2021 | REGION HOVEDSTADEN | KONGENS VAENGE 2 | HILLEROD | | | | DNK | R01AA025071 | Glucagon-like peptide-1 modulation of alcohol effects | 003 | 5 | NIH | 7/1/2021 | $121,272 |
| | 2021 | 2020 | REGION HOVEDSTADEN | KONGENS VAENGE 2 | HILLEROD | | | | DNK | R01AA025071 | Glucagon-like peptide-1 modulation of alcohol effects | 002 | 4 | NIH | 2/2/2021 | $33,837 |
| | 2021 | 2020 | REGION HOVEDSTADEN | KONGENS VAENGE 2 | HILLEROD | | | | DNK | R01AA025071 | Glucagon-like peptide-1 modulation of alcohol effects | 000 | 4 | NIH | 11/23/2020 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $317,205 ) |
| | 2020 | 2020 | REGION HOVEDSTADEN | KONGENS VAENGE 2 | HILLEROD | | 3400 | | DNK | R01AA025071 | Glucagon-like peptide-1 modulation of alcohol effects | 001 | 4 | NIH | 9/19/2020 | $122,522 |
| | 2020 | 2020 | REGION HOVEDSTADEN | KONGENS VAENGE 2 | HILLEROD | | 3400 | | DNK | R01CA236816 | Prenatal Exposure to Endocrine Disrupting Chemicals and Risk of Testicular Cancer (DISRUPT) | 000 | 1 | NIH | 4/10/2020 | $194,683 |
|
|
